Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference7 articles.
1. Aapro MS, Bohlius J, Cameron DA et al (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47(1):8–32
2. European Medicine Agency Evaluation of Medicines for Human Use. Assessment report for Tevagrastim. EMEA/503293/2008. Procedure no. EMEA/H/C/827
3. European Medicine Agency Evaluation of Medicines for Human Use. Assessment report for Ratiograstim EMEA/502481/2008. Procedure no. EMEA/H/C/825
4. European Medicine Agency Evaluation of Medicines for Human Use. Assessment report for Zarzio. EMEA/CHMP/651339/2008. Procedure no. EMEA/H/C/000917
5. European Medicines Agency. CHMO Assessment report for Nivestim. EMEA/262762/2010. Procedure no. EMEA/H/C/001142
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献